Literature DB >> 8446785

Human endothelial cells isolated from the hepatic sinusoids and the umbilical vein display a different permissiveness for HIV1.

M E Lafon1, J L Gendrault, C Royer, D Jaeck, A Kirn, A M Steffan.   

Abstract

Endothelial cells are now considered as potential targets for HIV infection, together with other non-lymphoid cells. We previously demonstrated that endothelial cells isolated from the human liver sinusoids (SEC) are permissive for HIV1 in vitro (Steffan et al., 1992), whereas human umbilical vein endothelial cells (HUVEC) do not allow replication of seven HIV1 and HIV2 strains under the same infection conditions (Lafon et al., 1992). The aim of our work was to compare the permissiveness of SEC and HUVEC and to determine whether the lack of HIV replication in HUVEC, which do not possess CD4 receptors (Lafon et al., 1992), could be related to the absence of virus penetration. The bypass of the early events in the virus life cycle, including the stage of fusion, by transfection of HUVEC with the HTLV-IIIB provirus led to one cycle of viral replication. Moreover, a low level of viral replication was observed in HUVEC infected with the NDK HIV strain, known to penetrate its target cell in a CD4-independent fashion. These results indicate that the block of infection in HUVEC takes place during the early stages of the viral replicative cycle. However, given the low level of NDK replication in HUVEC (0.02% infected cells) in comparison with NDK-infected SEC (30 to 50% infected cells), the absence of the CD4 receptor on HUVEC may not be the only limiting factor for viral growth. Although these two types of endothelial cells display a very different permissiveness for HIV, the present data suggest that they could both serve as a viral reservoir.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446785     DOI: 10.1016/s0923-2516(06)80018-x

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  8 in total

Review 1.  In vitro methods in the study of viral and prion permeability across the blood-brain barrier.

Authors:  Ryota Nakaoke; William A Banks
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

2.  Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis.

Authors:  W A Banks; E O Freed; K M Wolf; S M Robinson; M Franko; V B Kumar
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Gp120 activates children's brain endothelial cells via CD4.

Authors:  M F Stins; Y Shen; S H Huang; F Gilles; V K Kalra; K S Kim
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

Review 4.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

5.  Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infection.

Authors:  P P Sfikakis; V Tzavara; N Sipsas; O Kosmopoulou; P Sfikakis; T Kordossis
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

6.  Equine endothelial cells support productive infection of equine infectious anemia virus.

Authors:  W Maury; J L Oaks; S Bradley
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

7.  Culture and characterization of sinusoidal endothelial cells isolated from human liver.

Authors:  G W Daneker; S A Lund; S W Caughman; R A Swerlick; A H Fischer; C A Staley; E W Ades
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-05       Impact factor: 2.723

Review 8.  Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.

Authors:  Marisa Di Pietro; Simone Filardo; Francesca Falasca; Ombretta Turriziani; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2017-11-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.